By Jeff Overley ( September 24, 2013, 6:57 PM EDT) -- The U.S. Food and Drug Administration's release this week of final guidance on mobile medical apps provides much-needed clarity, yet it also leaves big questions unanswered and signals that ramped-up enforcement awaits, experts say. Here, attorneys share with Law360 their seven biggest takeaways....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.